Company Analysis

Cocrystal Pharma, Inc. (COCP)

Nasdaq: COCP · Pharmaceutical Preparations · Bothell, WA · filing with the SEC since 2007
Grade5.1
◀ Past 5.3● Present 3.9▶ Future 6.0
5 est.

Who runs Cocrystal Pharma, Inc.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Sapirstein James
Chief Executive Officer. First filing Jun 2026, latest Jun 3, 2026, 0 filings in all.
Officers reporting now
3
of 10 people with a filing in the last fifteen months
Directors reporting now
7
16 people on the record since 2014
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Sapirstein JamesChief Executive OfficerJun 2026Jun 3, 2026none
Lee SamPresident and Co-CEOMar 2014Jan 13, 2026none
Martin James JosephCo-CEO and CFOMar 2017Jan 13, 2026none
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameRoleFirst filingLatest filingSales, 12 months
Brosgart Carol LdirectorAug 2026Aug 21, 2026none
Frost Phillip Md Et AldirectorMar 2014Aug 6, 2026none
Hassan FreddirectorApr 2023Jan 13, 2026none
Japour Anthony JdirectorApr 2019Jan 13, 2026none
Kornberg Roger D.directorMar 2014Jan 13, 2026none
Pfenniger Richard C JrdirectorJun 2021Jan 13, 2026none
Rubin Steven DdirectorMar 2014Jan 13, 2026none
Earlier names on the record7, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton COCP · research, not advice